Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Flow cytometric characterization of tumor subpopulations in three sublines of the Dunning R3327 rat prostate tumor model.

Glowa C, Peschke P, Karger CP, Hahn EW, Huber PE, Debus J, Ehemann V.

Prostate. 2013 Nov;73(15):1710-20. doi: 10.1002/pros.22710. Epub 2013 Jul 12.

PMID:
23853045
2.

LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-β and BMP-associated proinflammatory and proangiogenic signals.

Flechsig P, Dadrich M, Bickelhaupt S, Jenne J, Hauser K, Timke C, Peschke P, Hahn EW, Gröne HJ, Yingling J, Lahn M, Wirkner U, Huber PE.

Clin Cancer Res. 2012 Jul 1;18(13):3616-27. doi: 10.1158/1078-0432.CCR-11-2855. Epub 2012 Apr 30.

3.

Multimodality imaging of hypoxia in preclinical settings.

Mason RP, Zhao D, Pacheco-Torres J, Cui W, Kodibagkar VD, Gulaka PK, Hao G, Thorpe P, Hahn EW, Peschke P.

Q J Nucl Med Mol Imaging. 2010 Jun;54(3):259-80. Review.

4.

Comparison of 1H blood oxygen level-dependent (BOLD) and 19F MRI to investigate tumor oxygenation.

Zhao D, Jiang L, Hahn EW, Mason RP.

Magn Reson Med. 2009 Aug;62(2):357-64. doi: 10.1002/mrm.22020.

5.

Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor.

Bourke VA, Zhao D, Gilio J, Chang CH, Jiang L, Hahn EW, Mason RP.

Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1179-86.

6.

Influence of different dose rates on cell recovery and RBE at different spatial positions during protracted conformal radiotherapy.

Herskind C, Schalla S, Hahn EW, Höver KH, Wenz F.

Radiat Prot Dosimetry. 2006;122(1-4):498-505. Epub 2007 Jan 12.

PMID:
17223644
8.

Tumor physiologic response to combretastatin A4 phosphate assessed by MRI.

Zhao D, Jiang L, Hahn EW, Mason RP.

Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):872-80.

PMID:
15936572
9.

Tumor oximetry: comparison of 19F MR EPI and electrodes.

Mason RP, Hunjan S, Constantinescu A, Song Y, Zhao D, Hahn EW, Antich PP, Peschke P.

Adv Exp Med Biol. 2003;530:19-27.

PMID:
14562701
10.

Tumor oxygen dynamics: correlation of in vivo MRI with histological findings.

Zhao D, Ran S, Constantinescu A, Hahn EW, Mason RP.

Neoplasia. 2003 Jul-Aug;5(4):308-18. doi: 10.1016/S1476-5586(03)80024-6.

11.

Correlation of tumor oxygen dynamics with radiation response of the dunning prostate R3327-HI tumor.

Zhao D, Constantinescu A, Chang CH, Hahn EW, Mason RP.

Radiat Res. 2003 May;159(5):621-31.

PMID:
12710873
12.

Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge.

Zhao D, Constantinescu A, Hahn EW, Mason RP.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):744-56.

PMID:
12062621
13.

Tumor oxygen dynamics with respect to growth and respiratory challenge: investigation of the Dunning prostate R3327-HI tumor.

Zhao D, Constantinescu A, Hahn EW, Mason RP.

Radiat Res. 2001 Nov;156(5 Pt 1):510-20.

PMID:
11604064
14.

Prognostic radiology: quantitative assessment of tumor oxygen dynamics by MRI.

Zhao D, Constantinescu A, Jiang L, Hahn EW, Mason RP.

Am J Clin Oncol. 2001 Oct;24(5):462-6.

PMID:
11586097
15.

Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor.

Hunjan S, Zhao D, Constantinescu A, Hahn EW, Antich PP, Mason RP.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1097-108.

PMID:
11240252
16.

Albumin as a carrier system for delivering drugs to solid tumors.

Schlicker A, Peschke P, Sinn H, Hahn EW.

PDA J Pharm Sci Technol. 2000 Nov-Dec;54(6):442-8. No abstract available.

PMID:
11107836
17.

Regional tumor oxygenation and measurement of dynamic changes.

Mason RP, Constantinescu A, Hunjan S, Le D, Hahn EW, Antich PP, Blum C, Peschke P.

Radiat Res. 1999 Sep;152(3):239-49.

PMID:
10453084
18.

Synergistic interaction of ultrasonic shock waves and hyperthermia in the Dunning prostate tumor R3327-AT1.

Huber P, Peschke P, Brix G, Hahn EW, Lorenz A, Tiefenbacher U, Wannenmacher M, Debus J.

Int J Cancer. 1999 Jul 2;82(1):84-91.

19.

Morphometric analysis of bromodeoxyuridine distribution and cell density in the rat Dunning prostate tumor R3327-AT1 following treatment with radiation and/or hyperthermia.

Peschke P, Klein V, Wolber G, Friedrich E, Hahn EW.

Histol Histopathol. 1999 Apr;14(2):461-9. doi: 10.14670/HH-14.461.

PMID:
10212807
20.

4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.

Schlicker A, Peschke P, Bürkle A, Hahn EW, Kim JH.

Int J Radiat Biol. 1999 Jan;75(1):91-100.

PMID:
9972795
21.

Regional tumor oxygen tension: fluorine echo planar imaging of hexafluorobenzene reveals heterogeneity of dynamics.

Mason RP, Hunjan S, Le D, Constantinescu A, Barker BR, Wong PS, Peschke P, Hahn EW, Antich PP.

Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):747-50.

PMID:
9845089
22.

Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia.

Peschke P, Hahn EW, Wenz F, Lohr F, Braunschweig F, Wolber G, Zuna I, Wannenmacher M.

Radiat Res. 1998 Oct;150(4):423-30.

PMID:
9768856
23.
24.

Regional tumor oximetry: 19F NMR spectroscopy of hexafluorobenzene.

Hunjan S, Mason RP, Constantinescu A, Peschke P, Hahn EW, Antich PP.

Int J Radiat Oncol Biol Phys. 1998 Apr 1;41(1):161-71.

PMID:
9588931
25.

Changes in RBE of 14-MeV (d + T) neutrons for V79 cells irradiated in air and in a phantom: is RBE enhanced near the surface?

Schalla S, Herskind C, Höver KH, Lorenz WJ, Hahn EW.

Strahlenther Onkol. 1998 Apr;174(4):204-11.

PMID:
9581181
26.

Dose-response relationship for late functional changes in the rat brain after radiosurgery evaluated by magnetic resonance imaging.

Karger CP, Hartmann GH, Peschke P, Debus J, Hoffmann U, Brix G, Hahn EW, Lorenz WJ.

Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1163-72.

PMID:
9392559
27.
28.

Stereotactic radiosurgery of the rat dunning R3327-AT1 prostate tumor.

Henke K, Hartmann GH, Peschke P, Hahn EW.

Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):385-91.

PMID:
8892464
29.

Growth-state-dependent radiation-induced expression of the proto-oncogene c-fos in NIH 3T3 cells.

Herskind C, Haas S, Flentje M, Hahn EW.

Radiat Res. 1996 Mar;145(3):299-303.

PMID:
8927697
30.

Non-invasive determination of tumor oxygen tension and local variation with growth.

Mason RP, Antich PP, Babcock EE, Constantinescu A, Peschke P, Hahn EW.

Int J Radiat Oncol Biol Phys. 1994 Apr 30;29(1):95-103.

PMID:
8175452
31.

In vivo detection of ultrasonically induced cavitation by a fibre-optic technique.

Huber P, Debus J, Peschke P, Hahn EW, Lorenz WJ.

Ultrasound Med Biol. 1994;20(8):811-25.

PMID:
7863570
32.

Measurement of the proliferative activity of three different sublines of the Dunning rat prostate tumor R3327.

Lohr F, Wenz F, Flentje M, Peschke P, Hahn EW.

Strahlenther Onkol. 1993 Jul;169(7):438-45.

PMID:
8342118
33.

[The relative biological effectiveness (RBE) of fast neutrons on the Dunning rat prostate carcinoma R3327-HI].

Wenz F, Lohr F, Peschke P, Wolber G, Höver KH, Hahn EW.

Strahlenther Onkol. 1993 Jul;169(7):412-7. German.

PMID:
8342114
34.

Isolated tumor growth in a surgically formed skin pedicle in the rat: a new tumor model for NMR studies.

Hahn EW, Peschke P, Mason RP, Babcock EE, Antich PP.

Magn Reson Imaging. 1993;11(7):1007-17.

PMID:
8231664
35.

Response of the rat Dunning R3327-AT1 prostate tumor to treatment with fractionated fast neutrons.

Peschke P, Lohr F, Hahn EW, Wolber G, Hoever KH, Wenz F, Lorenz WJ.

Radiat Res. 1992 Jan;129(1):112-4.

PMID:
1728053
36.

Treatment of the Dunning prostate rat tumor R3327-AT1 with pulsed high energy ultrasound shock waves (PHEUS): growth delay and histomorphologic changes.

Debus J, Peschke P, Hahn EW, Lorenz WJ, Lorenz A, Ifflaender H, Zabel HJ, Van Kaick G, Pfeiler M.

J Urol. 1991 Oct;146(4):1143-6.

PMID:
1895442
37.

Activity of various amphiphilic agents in reversing multidrug resistance of L 1210 cells.

Pommerenke EW, Osswald H, Hahn EW, Volm M.

Cancer Lett. 1990 Nov 19;55(1):17-23.

PMID:
2245406
38.

Response of the R3327-AT1 Dunning prostate tumor to fast neutrons and cobalt-60.

Hahn EW, Wolber G, Bak M, Hoever KH, Gerlach L, Volm M, Lorenz WJ.

Strahlenther Onkol. 1989 Apr;165(4):283-5.

PMID:
2711333
39.

Human tumor xenografts as model for drug testing.

Mattern J, Bak M, Hahn EW, Volm M.

Cancer Metastasis Rev. 1988 Nov;7(3):263-84. Review.

PMID:
3067903
40.
41.

DNA and S-phase distribution and incidence of metastasis in human primary lung carcinoma.

Volm M, Bak M, Hahn EW, Mattern J, Weber E.

Cytometry. 1988 Mar;9(2):183-8.

42.

Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test.

Volm M, Drings P, Hahn EW, Mattern J.

Br J Cancer. 1988 Feb;57(2):198-200. No abstract available.

43.

Gamma processing of Arabic bread for immune system-compromised cancer patients.

Grecz N, Brannon R, Jaw R, Al-Harithy R, Hahn EW.

Appl Environ Microbiol. 1985 Dec;50(6):1531-4.

44.

Medical gamma processing facility in Riyadh, Saudi Arabia, and radiation applications.

Grecz N, Hahn EW, Jouris WE.

Int J Appl Radiat Isot. 1985 Sep;36(9):741-2. No abstract available.

PMID:
4066068
45.

Improved response of a murine fibrosarcoma (Meth-A) to interstitial radiation when combined with hyperthermia.

Moorthy CR, Hahn EW, Kim JH, Feingold SM, Alfieri AA, Hilaris BS.

Int J Radiat Oncol Biol Phys. 1984 Nov;10(11):2145-8.

PMID:
6490440
46.

Glass-ceramic-mediated, magnetic-field-induced localized hyperthermia: response of a murine mammary carcinoma.

Luderer AA, Borrelli NF, Panzarino JN, Mansfield GR, Hess DM, Brown JL, Barnett EH, Hahn EW.

Radiat Res. 1983 Apr;94(1):190-8.

PMID:
6856765
47.

Hypoxic cell radiosensitization by moderate hyperthermia and glucose deprivation.

Kim JH, Kim SH, Hahn EW.

Radiat Res. 1983 Feb;93(2):416-20.

PMID:
6823521
48.

Combination hyperthermia and radiation therapy for malignant melanoma.

Kim JH, Hahn EW, Ahmed SA.

Cancer. 1982 Aug 1;50(3):478-82.

PMID:
7093890
49.

Recovery from aspermia induced by low-dose radiation in seminoma patients.

Hahn EW, Feingold SM, Simpson L, Batata M.

Cancer. 1982 Jul 15;50(2):337-40.

PMID:
7083140
50.

Radiofrequency hyperthermia for clinical cancer therapy.

Kim JH, Hahn EW, Antich PP.

Natl Cancer Inst Monogr. 1982 Jun;61:339-42.

PMID:
6757751

Supplemental Content

Support Center